Robby Potashnick is a seasoned finance executive with more than 20 years of experience in capital markets, accounting, financial leadership, and strategic planning. Since October 2024, he has provided consulting services through Oasis Business Consulting, LLC, including serving Envoy Medical since June 2025.
Prior to founding Oasis Business Consulting, Mr. Potashnick served as Chief Financial Officer of Flutterbee Education Group and FOXO Technologies, Inc. (NYSE American: FOXO), where he led financial operations, capital markets activities, SEC reporting, and corporate strategy initiatives. Earlier in his career, he held capital planning and business development finance roles at UnitedHealth Group (NYSE: UNH), supporting enterprise growth and strategic investment initiatives. He also worked at PricewaterhouseCoopers LLP, where he advised clients on technical accounting matters, financial reporting, and capital markets transactions.
Mr. Potashnick holds a Bachelor of Arts in Economics from Northwestern University, a Master of Accountancy from the University of Illinois, and an MBA with concentrations in Finance and Strategy from DePaul University. He currently serves on the boards of Wayzata Youth Wrestling and Mini Hops Gymnastics.
What is Robert Potashnick's net worth?
The estimated net worth of Robert Potashnick is at least $153.21 thousand as of February 12th, 2026. Mr. Potashnick owns 212,500 shares of Envoy Medical stock worth more than $153,213 as of September 23rd. This net worth estimate does not reflect any other investments that Mr. Potashnick may own. Learn More about Robert Potashnick's net worth.
How do I contact Robert Potashnick?
Has Robert Potashnick been buying or selling shares of Envoy Medical?
Robert Potashnick has not been actively trading shares of Envoy Medical in the last ninety days. Most recently, on Thursday, February 12th, Robert Potashnick bought 212,500 shares of Envoy Medical stock. The stock was acquired at an average cost of $0.40 per share, with a total value of $85,000.00. Following the completion of the transaction, the chief financial officer now directly owns 212,500 shares of the company's stock, valued at $85,000. Learn More on Robert Potashnick's trading history.
Who are Envoy Medical's active insiders?
Are insiders buying or selling shares of Envoy Medical?
In the last year, Envoy Medical insiders bought shares 6 times. They purchased a total of 20,433,650 shares worth more than $8,173,460.00. The most recent insider tranaction occured on February, 12th when Major Shareholder Glen A Taylor bought 18,750,000 shares worth more than $7,500,000.00. Insiders at Envoy Medical own 7.2% of the company.
Learn More about insider trades at Envoy Medical. Information on this page was last updated on 2/12/2026.
